On November 10th, Jiangsu Hengrui Pharmaceuticals (01276) spent 3.6684 million yuan to repurchase 60,000 shares of A shares.

16:54 10/11/2025

Hengrui Medicine (01276) announced that on November 10, 2025, the company invested RMB 366.8 million.

Jiangsu Hengrui Pharmaceuticals (01276) announced that on November 10, 2025, the company plans to spend 3.6684 million yuan to repurchase 60,000 shares of A shares, with a repurchase price of 61.00-61.31 yuan per share.

GUOFUHEE (02582) issued 242,800 shares due to the exercise of share warrants.

Dawei Technology (Guangdong) Group (600589.SH) plans to list and transfer some assets to focus on its core business.

EV Dynamics (00476) plans to offer a discount of approximately 14.29% for the rights issue, raising a maximum net amount of approximately HK$20 million.

GUOFUHEE (02582) issued 242,800 shares due to the exercise of share warrants.

Dawei Technology (Guangdong) Group (600589.SH) plans to list and transfer some assets to focus on its core business.

EV Dynamics (00476) plans to offer a discount of approximately 14.29% for the rights issue, raising a maximum net amount of approximately HK$20 million.